BRPI0511067A - processo para a formulação de formas de dosagem de dispersão rápida compreendendo pelo menos uma gelatina de peixe selecionada com base no peso molecular - Google Patents

processo para a formulação de formas de dosagem de dispersão rápida compreendendo pelo menos uma gelatina de peixe selecionada com base no peso molecular

Info

Publication number
BRPI0511067A
BRPI0511067A BRPI0511067-0A BRPI0511067A BRPI0511067A BR PI0511067 A BRPI0511067 A BR PI0511067A BR PI0511067 A BRPI0511067 A BR PI0511067A BR PI0511067 A BRPI0511067 A BR PI0511067A
Authority
BR
Brazil
Prior art keywords
molecular weight
gelatin
carrier
dosage forms
fish gelatin
Prior art date
Application number
BRPI0511067-0A
Other languages
English (en)
Inventor
Desmond Yik Teng Wong
Andrzej Jan Brzozowski
Leon Paul Grother
Original Assignee
Scherer Technologies Inc R P
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Scherer Technologies Inc R P filed Critical Scherer Technologies Inc R P
Publication of BRPI0511067A publication Critical patent/BRPI0511067A/pt
Publication of BRPI0511067B1 publication Critical patent/BRPI0511067B1/pt
Publication of BRPI0511067B8 publication Critical patent/BRPI0511067B8/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/46—Ingredients of undetermined constitution or reaction products thereof, e.g. skin, bone, milk, cotton fibre, eggshell, oxgall or plant extracts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4468—Non condensed piperidines, e.g. piperocaine having a nitrogen directly attached in position 4, e.g. clebopride, fentanyl
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/39—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin, cold insoluble globulin [CIG]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2063—Proteins, e.g. gelatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Physiology (AREA)
  • Nutrition Science (AREA)
  • Emergency Medicine (AREA)
  • Botany (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

PROCESSO PARA A FORMULAçãO DE FORMAS DE DOSAGEM DE DISPERSãO RáPIDA COMPREENDENDO PELO MENOS UMA GELATINA DE PEIXE SELECIONADA COM BASE NO PESO MOLECULAR. A invenção descrita aqui, neste pedido de patente refere-se a uma composição farmacêutica que compreende um veículo e um ingrediente ativo, na qual o veículo é pelo menos uma gelatina de peixe predeterminada com base no perfil do peso molecular da gelatina. Em algumas modalidades, especificamente quando a concentração do veículo compreende uma percentagem relativamente baixa do total da composição, o veículo pode ser exclusivamente uma gelatina de peixe de alto peso molecular, ou pode ser composto de uma mistura com uma gelatina de peso molecular padrão, na qual a gelatina de alto peso molecular compreende uma parte predominante. Naquelas modalidades nas quais a concentração do veículo compreende uma percentagem relativamente maior do total da composição, o veículo pode ser uma gelatina de peixe exclusivamente de peso molecular padrão, ou pode ser composto por uma mistura na qual a gelatina de peso molecular padrão compreende uma parte predominante. Dessa forma, podem ser projetadas composições para otimizar o desempenho com relação a diversas formulações de concentrações de gelatina requeridas.
BRPI0511067A 2004-06-03 2005-06-03 processo para a formulação de formas de dosagem de dispersão rápida e forma de dosagem oral, sólida, de desintegração rápida de uma substância farmaceuticamente ativa BRPI0511067B8 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US10/860,106 US7972621B2 (en) 2004-06-03 2004-06-03 Process for formulating fast dispersing dosage forms comprising at least one fish gelatin selected on the basis of molecular weight
PCT/US2005/019589 WO2005120464A1 (en) 2004-06-03 2005-06-03 Process for formulating fast dispersing dosage forms comprising at least one fish gelatin selected on the basis of molecular weight

Publications (3)

Publication Number Publication Date
BRPI0511067A true BRPI0511067A (pt) 2007-12-26
BRPI0511067B1 BRPI0511067B1 (pt) 2018-11-06
BRPI0511067B8 BRPI0511067B8 (pt) 2021-05-25

Family

ID=35449231

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0511067A BRPI0511067B8 (pt) 2004-06-03 2005-06-03 processo para a formulação de formas de dosagem de dispersão rápida e forma de dosagem oral, sólida, de desintegração rápida de uma substância farmaceuticamente ativa

Country Status (19)

Country Link
US (1) US7972621B2 (pt)
EP (1) EP1765299B1 (pt)
JP (1) JP5144258B2 (pt)
KR (1) KR101161430B1 (pt)
CN (2) CN1960710A (pt)
AU (1) AU2005251773B2 (pt)
BR (1) BRPI0511067B8 (pt)
CA (1) CA2567830C (pt)
DK (1) DK1765299T3 (pt)
ES (1) ES2654293T3 (pt)
HU (1) HU230429B1 (pt)
IL (1) IL179777A (pt)
IS (1) IS8588A (pt)
MX (1) MXPA06013921A (pt)
NO (1) NO342135B1 (pt)
PL (2) PL1765299T3 (pt)
RU (1) RU2415665C2 (pt)
WO (1) WO2005120464A1 (pt)
ZA (1) ZA200610664B (pt)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9908014D0 (en) * 1999-04-08 1999-06-02 Scherer Corp R P Pharmaceutical compositions
US20060210590A1 (en) 2005-02-03 2006-09-21 Alk-Abello A/S Minor allergen control to increase safety of immunotherapy
BRPI0611526A2 (pt) * 2005-05-19 2009-11-24 Aqua Bio Technology Asa composição tópica contendo gelatina
DE102006033168A1 (de) * 2006-07-10 2008-01-17 Gelita Ag Verwendung von Gelatine und einem Vernetzungsmittel zur Herstellung einer vernetzenden therapeutischen Zusammensetzung
US20090226522A1 (en) * 2008-02-28 2009-09-10 Howes Simon A M Process to minimize polymorphism
US10548839B2 (en) 2010-03-16 2020-02-04 Wei Tian Process of manufacturing a lyophilized fast dissolving, multi-phasic dosage form
JP6061859B2 (ja) * 2010-10-08 2017-01-18 アール．ピー． シェーラー テクノロジーズ エルエルシー デンプンを使用する経口ワクチン速溶性剤型
CN110337290A (zh) 2016-12-31 2019-10-15 比奥克斯塞尔医疗股份有限公司 舌下右旋美托咪啶用于治疗激越的用途
EP4523752A3 (en) 2018-06-27 2025-05-14 BioXcel Therapeutics, Inc. Film formulations containing dexmedetomidine and methods of producing them
US11523988B2 (en) 2018-11-29 2022-12-13 Catalent U.K. Swindon Zydis Limited Oral dispersible vaccine comprising virosomes
JP7739256B2 (ja) 2019-07-19 2025-09-16 バイオエクセル セラピューティクス，インコーポレイテッド 鎮静作用のないデクスメデトミジン治療レジメン
EP4213805A1 (en) * 2020-09-17 2023-07-26 Catalent U.K. Swindon Zydis Limited Use of surfactant with high molecular weight fish gelatin based dosage formulations to improve flow characteristics
WO2022074127A2 (en) * 2020-10-08 2022-04-14 Catalent U.K. Swindon Zydis Limited Stable oral dispersible formulation for epinephrine and salts or solvates thereof
EP4243602A4 (en) 2020-11-16 2024-11-13 Orcosa Inc. Improved use of cannabinoids in the treatment of alzheimer's disease
US11672761B2 (en) 2020-11-16 2023-06-13 Orcosa Inc. Rapidly infusing platform and compositions for therapeutic treatment in humans
WO2022261499A1 (en) 2021-06-11 2022-12-15 AI Therapeutics, Inc. Stabilized apilimod compositions and uses thereof
US11806334B1 (en) 2023-01-12 2023-11-07 Bioxcel Therapeutics, Inc. Non-sedating dexmedetomidine treatment regimens

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1548022A (en) 1976-10-06 1979-07-04 Wyeth John & Brother Ltd Pharmaceutial dosage forms
GB2111423B (en) 1981-12-02 1985-06-26 Wyeth John & Brother Ltd Making quick-dissolving pills
US4760094A (en) 1986-10-21 1988-07-26 American Home Products Corporation (Del.) Spray dried acetaminophen
US4760093A (en) 1986-10-21 1988-07-26 American Home Products Corporation (Del.) Spray dried acetaminophen
US4767789A (en) 1986-10-21 1988-08-30 American Home Products Corporation (Del.) Spray dried acetaminophen
US5039540A (en) 1989-08-14 1991-08-13 Neophore Technologies, Inc. Freeze dry composition and method for oral administration of drugs, biologicals, nutrients and foodstuffs
US5079018A (en) 1989-08-14 1992-01-07 Neophore Technologies, Inc. Freeze dry composition and method for oral administration of drugs, biologicals, nutrients and foodstuffs
US5215756A (en) 1989-12-22 1993-06-01 Gole Dilip J Preparation of pharmaceutical and other matrix systems by solid-state dissolution
US5298261A (en) 1992-04-20 1994-03-29 Oregon Freeze Dry, Inc. Rapidly distintegrating tablet
IL105553A (en) * 1992-05-06 1998-01-04 Janssen Pharmaceutica Inc Solid dosage form comprising a porous network of matrix forming material which disperses rapidly in water
US5474854A (en) 1992-11-11 1995-12-12 Toray Industries, Inc. Polyester composition and film made therefrom
US6726928B2 (en) 1994-10-28 2004-04-27 R.P. Scherer Technologies, Inc. Process for preparing solid dosage forms for unpalatable pharmaceuticals
GB9517062D0 (en) * 1995-08-18 1995-10-25 Scherer Ltd R P Pharmaceutical compositions
PT910339E (pt) 1996-04-12 2005-05-31 Novadel Pharma Inc Aerossol polar bucal
US6258380B1 (en) 1999-03-05 2001-07-10 Banner Pharmacaps, Inc. Chewable soft capsule
GB9908014D0 (en) * 1999-04-08 1999-06-02 Scherer Corp R P Pharmaceutical compositions
US6284270B1 (en) 1999-08-04 2001-09-04 Drugtech Corporation Means for creating a mass having structural integrity
US6709699B2 (en) * 2000-09-27 2004-03-23 Kabushiki Kaisha Toshiba Film-forming method, film-forming apparatus and liquid film drying apparatus
US6706669B2 (en) * 2001-07-13 2004-03-16 Exxonmobil Research And Engineering Company Method for inhibiting corrosion using phosphorous acid
CA2484724C (en) * 2002-05-07 2007-01-16 Ferring B.V. Pharmaceutical formulations
GB0210397D0 (en) 2002-05-07 2002-06-12 Ferring Bv Pharmaceutical formulations
GB2388776B (en) * 2002-05-21 2004-08-25 Croda Int Plc Succinylated fish gelatin for use as a blood plasma expander
GB0226076D0 (en) 2002-11-08 2002-12-18 Rp Scherer Technologies Inc Improved formulations containing substituted imidazole derivatives

Also Published As

Publication number Publication date
IS8588A (is) 2006-12-28
JP2008501709A (ja) 2008-01-24
US20050271719A1 (en) 2005-12-08
IL179777A0 (en) 2007-05-15
IL179777A (en) 2015-09-24
KR101161430B1 (ko) 2012-07-02
CA2567830C (en) 2013-08-13
BRPI0511067B8 (pt) 2021-05-25
DK1765299T3 (en) 2018-01-22
PL382307A1 (pl) 2007-08-20
NO20066070L (no) 2007-02-27
MXPA06013921A (es) 2007-01-26
CN1960710A (zh) 2007-05-09
AU2005251773A1 (en) 2005-12-22
CN102172345B (zh) 2018-05-04
EP1765299B1 (en) 2017-11-15
PL1765299T3 (pl) 2018-05-30
BRPI0511067B1 (pt) 2018-11-06
ZA200610664B (en) 2007-12-27
NO342135B1 (no) 2018-03-26
RU2415665C2 (ru) 2011-04-10
ES2654293T3 (es) 2018-02-13
CN102172345A (zh) 2011-09-07
AU2005251773B2 (en) 2010-12-16
KR20070039524A (ko) 2007-04-12
US7972621B2 (en) 2011-07-05
HUP0700043A2 (en) 2009-03-02
JP5144258B2 (ja) 2013-02-13
EP1765299A4 (en) 2011-03-09
HUP0700043A3 (en) 2012-09-28
EP1765299A1 (en) 2007-03-28
PL218958B1 (pl) 2015-02-27
HU230429B1 (hu) 2016-06-28
CA2567830A1 (en) 2005-12-22
WO2005120464A1 (en) 2005-12-22
RU2006147244A (ru) 2008-07-20

Similar Documents

Publication Publication Date Title
BRPI0511067A (pt) processo para a formulação de formas de dosagem de dispersão rápida compreendendo pelo menos uma gelatina de peixe selecionada com base no peso molecular
BR122012030846B8 (pt) composição farmacêutica não aquosa para uso dermatológico compreendendo calcipotriol e pelo menos um corticoesteróide, e, uso da mesma
BR9909329A (pt) Método para estabilizar composições farmacêuticas pelo uso especial de um antioxidante
BRPI0615860B8 (pt) composição farmacêutica de liberação prolongada monolítica sólida
AR048878A1 (es) Composiciones topicas de metadona y metodos para usarlas
UY29157A1 (es) Composiciones de amitraz
AR060784A1 (es) Mezclas binarias de acido hialuronico y su uso terapeutico
BR0209689A (pt) Uso de fragmento de hmg como agente anti-inflamatório
BRPI0508540A (pt) composto, composição farmacêutica, e, uso de um composto
BR0313343A (pt) Uso de uma mistura de agentes permeantes, soluções para aplicação ungueal e periungueal e uso de uma solução para aplicação ungueal e periungueal
BRPI0506523A (pt) composição adesiva de époxi, seu uso e veìculo
BRPI0316532B8 (pt) composições farmacêuticas compreendendo uma droga básica ou ácida, um tensoativo, e um ácido ou base solúvel em água fisiologicamente tolerável
BRPI0612669B8 (pt) composição imunogênica, vacina, composição, e composição liofilizada
BRPI0607039A2 (pt) formulação, forma de dosagem unitária, uso de uma formulação, produto farmacêutico e, método para a preparação de um produto farmacêutico
BRPI0418011A (pt) óleo de base lubrificante, e, processo e instalação de fabricação do mesmo
BR0316310A (pt) Composições farmacêuticas tendo um veìculo modificado
BRPI0608840B8 (pt) composição farmacêutica compreendendo uma difenil uréia substituída por ômega-carboxiarila, e seu processo de preparação
BR0210595A (pt) Regime de dosagem e composição farmacêutica para contracepção de emergência
BR0313060A (pt) Composições farmacêuticas aquosas de 2,6-diisopropilfenol
CO5150236A1 (es) Metodo para tratar asma inducida por el ejercicio inducida por el ejercicio
BR112014001017A2 (pt) uso de um ou mais nucleotídeos para aperfeiçoar a estabilidade de calor de uma composição aquosa de caseína micelar; composição nutricional líquida; processo para o tratamento com calor de uma composição aquosa de caseína micelar; e método para prover nutrição a uma pessoa com necessidade desta
BRPI0408827A (pt) composições oftálmicas preservadas
BRPI0514411A (pt) formulação, e, método de produzir uma formulação
BRPI0607349A2 (pt) combinação de xolair com agente imunossupressor
BR0306878A (pt) Peptìdeo não-agonista do receptor de fator de liberação de corticotropina 2, ácido nucleico e anticorpo isolados, composição farmacêutica e kit compreendendo o referido peptìdeo e uso do referido peptìdeo e ácido nucleico na fabricação de um medicamento

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 06/11/2018, OBSERVADAS AS CONDICOES LEGAIS.

B16C Correction of notification of the grant [chapter 16.3 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 03/06/2005 OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF